Vilazodone (Viibryd) Part II
Evidence to date shows no significant benefit of the new selective serotonin reuptake inhibitor (SSRI) vilazodone (Viibryd) over other antidepressants.
Clozapine (Clozaril and others) carries a wide range of side effects, but it is still the most efficacious antipsychotic when patients are inadequately responsive to other agents.
New Cardiac Warning Added to Labeling for Quetiapine (Seroquel); Atomoxetine (Strattera) Does Not Attenuate Weight Gain in Patients with Schizophrenia
No Help from the "Sunshine Vitamin"
In a nonclinical elderly population, vitamin D supplementation had no significant effect on mood or other mental health outcomes.
In July, the US Food and Drug Administration requested that AstraZeneca add a new warning to the labeling for quetiapine (Seroquel) and extended-release quetiapine (Seroquel XR) stating that they should not be used concomitantly with certain medicines that prolong the QT interval (Wilson D. NY…